![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Randomized-controlled trial evaluating the outcome between switching to tenofovir disoproxil fumarate(TDF)/lamivudine(3TC)/dolutegravir(DTG)
versus maintaining the current NNRTI or boosted-PI-containing regimen in PLWH in Thailand - a pilot study from single center
|
|
|
ID Week 2023 Oct 13
![1016231](../images/101523/101523-5/1016231.gif)
![1016232](../images/101523/101523-5/1016232.gif)
![1016233](../images/101523/101523-5/1016233.gif)
![1016234](../images/101523/101523-5/1016234.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|